Developer docs
API playgroundTry for free, no card

Search company profiles

Suvoda

Full company profile

uuid0000v49

Namestring
Suvoda
Legal namestring
Suvoda LLC
Websiteurl
suvoda.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Suvoda is a privately held clinical trial technology company founded in 2013 and headquartered in Conshohocken, Pennsylvania, that provides enterprise software and services for pharmaceutical sponsors, contract research organizations (CROs), research sites, and clinical trial patients. Its unified platform comprises eight interconnected products: RTSM/IRT for randomization and drug supply management, eCOA for electronic clinical outcome assessments, eConsent for digital consent, Scheduling, a unified Patient App, Site Payments, Greenphire Patient Payments (ClinCard), Greenphire Travel (ConneX), and Budgeting & Benchmarking. The platform is built on a patented low-code/no-code architecture featuring a patented Virtual Partition multi-tenant design that maintains strict data separation and blinding across trials. Suvoda serves more than 1,000 clients across 115+ countries and has supported over 6,000 clinical trials, with 34% of FDA-approved trials since 2024 running on the platform and 65% of trials concentrated in oncology, rare disease, and CNS therapeutic areas.

Suvoda's revenue model is enterprise SaaS subscription-based with multi-year contracts, sold through direct field sales to large pharmaceutical companies, biotech firms, and CROs. Pricing is quote-based and varies by study scope, site count, geographic coverage, and module selection, with professional services attached for implementation and ongoing support. Following the April 2025 merger with Greenphire, the company expanded its platform to integrate patient payment and travel logistics alongside operational modules, creating an end-to-end clinical trial technology and financial management offering under the Suvoda name with backing from Thoma Bravo and Bain Capital Tech Opportunities.

The company is currently deploying two AI capabilities as differentiators: Sofia, a conversational AI assistant embedded in the IRT/RTSM platform with a three-layer deterministic architecture; and Agentic RTSM, which uses multiple AI agents to automate study builds, configuration, customization, and testing, with claimed reductions in trial startup timelines of up to 80%. Suvoda maintains offices in Conshohocken, Bucharest, Barcelona, and Tokyo, holds five patents with additional applications pending, and operates under GDPR, CCPA, and EU-U.S. Data Privacy Framework compliance to support cross-border data flows.

Short descriptiontext

Suvoda provides enterprise SaaS for clinical trial management, offering a unified platform with RTSM/IRT, eCOA, eConsent, patient payments, travel, and budgeting modules to pharmaceutical sponsors, CROs, research sites, and trial patients across 115+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersConshohocken, United States
HQ citystring
Conshohocken
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial technology, randomization trial supply management, electronic clinical outcomes, patient payment solutions, clinical trial budgeting
Industry2 codes
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code2 codes
  • Software Publishers513210
  • Computer Systems Design and Related Services5415
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
Product category
Clinical Trial Technology / eClinical Software
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Software Platform
TypeSubscription Recurring
Description

Suvoda generates revenue through enterprise SaaS licensing of its clinical trial technology platform, which includes modules for RTSM/IRT, eCOA, eConsent, Scheduling, Patient Payments, Travel, Budgeting & Benchmarking, and Site Payments. The company offers a unified platform approach following the merger with Greenphire. Revenue is generated through multi-year contracts with pharmaceutical sponsors, CROs, and research sites, typically structured as subscription-based licensing with professional services for implementation and support.

suvoda.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise SaaS licensing with modular pricing
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed. Pricing varies by study scope, number of sites, geographic coverage, and specific modules required (RTSM, eCOA, eConsent, Payments, etc.).

suvoda.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1Greenphire Patient Payments
Description

Patient payment and reimbursement solutions for clinical trial participants

suvoda.com
+5 more records
Core offering1 text field

Suvoda sells a unified, web-based clinical trial technology platform comprising eight modular products—RTSM/IRT, eCOA, eConsent, Patient Payments, Travel, Scheduling, Site Payments, and Budgeting & Benchmarking—delivered as multi-year enterprise SaaS subscriptions to pharmaceutical sponsors, CROs, and research sites. The platform is augmented by AI capabilities including the Sofia assistant and agentic RTSM, and supported by professional services for implementation, integration, and ongoing customer success.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Reduces clinical trial startup timelines by up to 80%
+5 more records
Product overview1 text field

Suvoda offers a unified clinical trial technology platform with eight interconnected products organized as a core platform plus modular solutions. The platform includes RTSM (IRT) for randomization and drug supply management, eCOA for electronic clinical outcome assessments, and eConsent for digital consent management. Following the 2025 merger with Greenphire, the platform expanded to include Greenphire Patient Payments (ClinCard) for participant stipends and reimbursements, and Greenphire Travel (ConneX) for travel logistics. Additional modules include Scheduling for visit management, a unified Patient App consolidating multiple patient-facing functions, Site Payments for investigator grants, and Budgeting & Benchmarking for financial planning with split budget support. The platform is powered by a patented low-code/no-code architecture and supports AI capabilities including the Sofia AI assistant and agentic RTSM for automated study configuration.

Product and service10 records
1Suvoda Platform
CategoryClinical Trial Technology Platform
Description

A unified clinical trial technology platform interconnecting RTSM, eCOA, eConsent, patient payments, travel, scheduling, site payments, and budgeting modules into a single ecosystem with real-time data synchronization across trial stakeholders. Designed for pharmaceutical sponsors, CROs, and research sites.

2RTSM (IRT)
CategoryClinical Trial Randomization & Supply Management
Description

Randomization and Trial Supply Management system with Interactive Response Technology capabilities for managing patient randomization, drug allocation, and supply chain logistics in clinical trials. Used by pharmaceutical sponsors and CROs across global trials.

3eCOA
CategoryElectronic Clinical Outcome Assessments
Description

Electronic Clinical Outcome Assessments solution for collecting patient-reported, clinician-reported, and observer-reported outcomes through digital questionnaires. Used by sponsors and CROs to capture trial endpoint data.

4eConsent
CategoryElectronic Consent Management
Description

Electronic consent solution enabling digital informed consent management for clinical trial participants, with integrated consent documentation and tracking across sites and studies.

5Greenphire Patient Payments (ClinCard)
CategoryClinical Trial Patient Payments
Description

Patient payment and reimbursement solution (formerly ClinCard) for managing stipends, travel reimbursements, and participant payments with automated disbursement and receipt tracking. Used by sponsors, CROs, and research sites to reimburse clinical trial participants.

6Greenphire Travel (ConneX)
CategoryClinical Trial Patient Travel Services
Description

Patient travel and logistics service (ConneX) for managing transportation, accommodation, and travel arrangements to reduce participation barriers for clinical trial participants. Used by sponsors and research sites.

7Scheduling
CategoryClinical Trial Visit Scheduling
Description

Visit scheduling module for managing patient appointments, site visit calendars, and study timeline coordination across trial sites. Used by sponsors, CROs, and sites to coordinate clinical trial visits.

8Patient App
CategoryClinical Trial Patient Engagement
Description

Unified mobile application consolidating visit scheduling, health questionnaires, travel information, receipt submission, and payment management into a single patient experience for clinical trial participants.

9Site Payments
CategoryClinical Trial Site Payments
Description

Investigator grant and site payment management solution for automating invoice generation, approval workflows, and payment execution to research sites conducting clinical trials.

10Budgeting & Benchmarking
CategoryClinical Trial Budgeting & Benchmarking
Description

Clinical trial financial planning solution with real-time fair market value benchmarking for site cost data, budget negotiation support, and multi-payee split budget management. Used by sponsors and CROs to negotiate and manage site budgets.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-10
Description

Advarra expanded its Study Collaboration solution to include integrations with eClinical technology partners including Suvoda. The integration creates a single sign-on (SSO) access point allowing sponsors, sites, and CROs to securely access multiple systems including IRT/RTSM through a unified interface. More than 225,000 study team members use the platform.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-04-24
Description

Suvoda and Greenphire completed their merger in April 2025, combining under the Suvoda name. The merger created a unified clinical trial technology platform integrating Greenphire's patient payment and travel solutions (ClinCard, ConneX travel service) with Suvoda's RTSM/IRT, eCOA, and eConsent products. The combined entity aims to provide end-to-end clinical trial technology and financial management, streamlining operations for sponsors, sites, and patients.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Veeva's Vault CTMS, Vault RTSM, and Vault eCOA directly compete with Suvoda's IRT/RTSM, eCOA, and eConsent offerings. Veeva is the largest publicly traded eClinical platform serving the same pharmaceutical sponsor and CRO customer base.

TypeDirect peer
Description

Medidata's Rave RTSM, Rave EDC, and eCOA solutions directly compete with Suvoda's core IRT, EDC-adjacent, and eCOA modules. Medidata serves the same enterprise pharma sponsors and CROs at comparable scale.

TypeDirect peer
Description

Oracle's Clinical One platform combines RTSM, EDC, and clinical trial operations in a unified suite directly comparable to Suvoda's platform approach. Oracle leverages its broader enterprise software relationships to win large pharma accounts.

TypeDirect peer
Description

Signant Health provides RTSM, eCOA, and clinical supply solutions that directly overlap Suvoda's core product portfolio. The company targets the same pharmaceutical and CRO customers and competes head-to-head on mid-sized and large trials.

TypeDirect peer
Description

Clario offers eCOA, RTSM, cardiac safety, and imaging solutions that compete directly with Suvoda's patient-centric clinical outcome assessment and IRT offerings. Clario was formed from the merger of ERT and Bioclinica.

TypeDirect peer
Description

Medrio provides EDC, eCOA, and direct data capture solutions to clinical trial sponsors and CROs. It serves a comparable mid-market segment and overlaps with Suvoda's eCOA and trial configuration capabilities.

TypeEmerging player
Description

Science 37 pioneered decentralized clinical trial technology and competes in adjacent patient-facing and remote trial capabilities. Suvoda's unified patient app and Greenphire travel/payments overlap with Science 37's decentralized model.

TypeEmerging player
Description

Advarra's Study Collaboration platform integrates with Suvoda and competing eClinical technologies, offering site-facing workflow, IRB, and technology orchestration. The integration partnership (Dec 2025) and overlap in site payments/feasibility make it a relevant adjacent peer.

TypeEmerging player
Description

Castor provides an eClinical platform with EDC, eCOA, and eConsent capabilities that competes in part with Suvoda's offering, particularly for smaller biotech and academic sponsors adopting cloud-based, configurable platforms.

TypeBroad incumbent
Description

IQVIA operates as a broad CRO and clinical technology incumbent with proprietary RTSM, EDC, and analytics offerings. Its size and CRO relationships position it as both a customer and a competitor to Suvoda in the eClinical technology market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Suvoda

Clinical Trial Technology / eClinical Softwaresuvoda.com

Suvoda provides enterprise SaaS for clinical trial management, offering a unified platform with RTSM/IRT, eCOA, eConsent, patient payments, travel, and budgeting modules to pharmaceutical sponsors, CROs, research sites, and trial patients across 115+ countries.

What Suvoda does

Suvoda is a privately held clinical trial technology company founded in 2013 and headquartered in Conshohocken, Pennsylvania, that provides enterprise software and services for pharmaceutical sponsors, contract research organizations (CROs), research sites, and clinical trial patients. Its unified platform comprises eight interconnected products: RTSM/IRT for randomization and drug supply management, eCOA for electronic clinical outcome assessments, eConsent for digital consent, Scheduling, a unified Patient App, Site Payments, Greenphire Patient Payments (ClinCard), Greenphire Travel (ConneX), and Budgeting & Benchmarking. The platform is built on a patented low-code/no-code architecture featuring a patented Virtual Partition multi-tenant design that maintains strict data separation and blinding across trials. Suvoda serves more than 1,000 clients across 115+ countries and has supported over 6,000 clinical trials, with 34% of FDA-approved trials since 2024 running on the platform and 65% of trials concentrated in oncology, rare disease, and CNS therapeutic areas.

Suvoda's revenue model is enterprise SaaS subscription-based with multi-year contracts, sold through direct field sales to large pharmaceutical companies, biotech firms, and CROs. Pricing is quote-based and varies by study scope, site count, geographic coverage, and module selection, with professional services attached for implementation and ongoing support. Following the April 2025 merger with Greenphire, the company expanded its platform to integrate patient payment and travel logistics alongside operational modules, creating an end-to-end clinical trial technology and financial management offering under the Suvoda name with backing from Thoma Bravo and Bain Capital Tech Opportunities.

The company is currently deploying two AI capabilities as differentiators: Sofia, a conversational AI assistant embedded in the IRT/RTSM platform with a three-layer deterministic architecture; and Agentic RTSM, which uses multiple AI agents to automate study builds, configuration, customization, and testing, with claimed reductions in trial startup timelines of up to 80%. Suvoda maintains offices in Conshohocken, Bucharest, Barcelona, and Tokyo, holds five patents with additional applications pending, and operates under GDPR, CCPA, and EU-U.S. Data Privacy Framework compliance to support cross-border data flows.

Suvoda firmographics

Firmographics
Name
Suvoda
Legal name
Suvoda LLC
Website
https://suvoda.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Suvoda provides enterprise SaaS for clinical trial management, offering a unified platform with RTSM/IRT, eCOA, eConsent, patient payments, travel, and budgeting modules to pharmaceutical sponsors, CROs, research sites, and trial patients across 115+ countries.
Ownership category
akta.pro rank

Suvoda industry classification

Industry
Product category
Clinical Trial Technology / eClinical Software
NAICS
Software Publishers (513210), Computer Systems Design and Related Services (5415)
SIC
Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Clinical trial technology
  • Randomization trial supply management
  • Electronic clinical outcomes
  • Patient payment solutions
  • Clinical trial budgeting

Where Suvoda is headquartered

Location

Headquarters

HQ city
Conshohocken
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Suvoda business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Clinical Trial Software Platform: Suvoda generates revenue through enterprise SaaS licensing of its clinical trial technology platform, which includes modules for RTSM/IRT, eCOA, eConsent, Scheduling, Patient Payments, Travel, Budgeting & Benchmarking, and Site Payments. The company offers a unified platform approach following the merger with Greenphire. Revenue is generated through multi-year contracts with pharmaceutical sponsors, CROs, and research sites, typically structured as subscription-based licensing with professional services for implementation and support.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise SaaS licensing with modular pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Suvoda product offering

Product offering

Core offering

Suvoda sells a unified, web-based clinical trial technology platform comprising eight modular products—RTSM/IRT, eCOA, eConsent, Patient Payments, Travel, Scheduling, Site Payments, and Budgeting & Benchmarking—delivered as multi-year enterprise SaaS subscriptions to pharmaceutical sponsors, CROs, and research sites. The platform is augmented by AI capabilities including the Sofia assistant and agentic RTSM, and supported by professional services for implementation, integration, and ongoing customer success.

Product overview

Suvoda offers a unified clinical trial technology platform with eight interconnected products organized as a core platform plus modular solutions. The platform includes RTSM (IRT) for randomization and drug supply management, eCOA for electronic clinical outcome assessments, and eConsent for digital consent management. Following the 2025 merger with Greenphire, the platform expanded to include Greenphire Patient Payments (ClinCard) for participant stipends and reimbursements, and Greenphire Travel (ConneX) for travel logistics. Additional modules include Scheduling for visit management, a unified Patient App consolidating multiple patient-facing functions, Site Payments for investigator grants, and Budgeting & Benchmarking for financial planning with split budget support. The platform is powered by a patented low-code/no-code architecture and supports AI capabilities including the Sofia AI assistant and agentic RTSM for automated study configuration.

Differentiator

Problem solved

Functional benefit

Brands

  • Greenphire Patient Payments: Patient payment and reimbursement solutions for clinical trial participants
  • Greenphire Travel
  • Sofia
  • ClinCard
  • ConneX
  • Clincierge

Products and services

  • Suvoda Platform A unified clinical trial technology platform interconnecting RTSM, eCOA, eConsent, patient payments, travel, scheduling, site payments, and budgeting modules into a single ecosystem with real-time data synchronization across trial stakeholders. Designed for pharmaceutical sponsors, CROs, and research sites.
  • RTSM (IRT) Randomization and Trial Supply Management system with Interactive Response Technology capabilities for managing patient randomization, drug allocation, and supply chain logistics in clinical trials. Used by pharmaceutical sponsors and CROs across global trials.
  • eCOA Electronic Clinical Outcome Assessments solution for collecting patient-reported, clinician-reported, and observer-reported outcomes through digital questionnaires. Used by sponsors and CROs to capture trial endpoint data.
  • eConsent Electronic consent solution enabling digital informed consent management for clinical trial participants, with integrated consent documentation and tracking across sites and studies.
  • Greenphire Patient Payments (ClinCard) Patient payment and reimbursement solution (formerly ClinCard) for managing stipends, travel reimbursements, and participant payments with automated disbursement and receipt tracking. Used by sponsors, CROs, and research sites to reimburse clinical trial participants.
  • Greenphire Travel (ConneX) Patient travel and logistics service (ConneX) for managing transportation, accommodation, and travel arrangements to reduce participation barriers for clinical trial participants. Used by sponsors and research sites.
  • Scheduling Visit scheduling module for managing patient appointments, site visit calendars, and study timeline coordination across trial sites. Used by sponsors, CROs, and sites to coordinate clinical trial visits.
  • Patient App Unified mobile application consolidating visit scheduling, health questionnaires, travel information, receipt submission, and payment management into a single patient experience for clinical trial participants.
  • Site Payments Investigator grant and site payment management solution for automating invoice generation, approval workflows, and payment execution to research sites conducting clinical trials.
  • Budgeting & Benchmarking Clinical trial financial planning solution with real-time fair market value benchmarking for site cost data, budget negotiation support, and multi-payee split budget management. Used by sponsors and CROs to negotiate and manage site budgets.

Quantifiable outcome

  • Reduces clinical trial startup timelines by up to 80%
  • +5 more outcomes

Companies that use Suvoda

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles4 records

Suvoda technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability7 records

Feature5 records

Suvoda partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and flagship.

  • AdvarracoreTechnology or Integration · 10 December 2025Advarra expanded its Study Collaboration solution to include integrations with eClinical technology partners including Suvoda. The integration creates a single sign-on (SSO) access point allowing sponsors, sites, and CROs to securely access multiple systems including IRT/RTSM through a unified interface. More than 225,000 study team members use the platform.
  • GreenphireflagshipStrategic or Co-development Partner · 24 April 2025Suvoda and Greenphire completed their merger in April 2025, combining under the Suvoda name. The merger created a unified clinical trial technology platform integrating Greenphire's patient payment and travel solutions (ClinCard, ConneX travel service) with Suvoda's RTSM/IRT, eCOA, and eConsent products. The combined entity aims to provide end-to-end clinical trial technology and financial management, streamlining operations for sponsors, sites, and patients.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Suvoda competitors and assessment

Company assessment

Direct peers

  • Veeva Systems: Veeva's Vault CTMS, Vault RTSM, and Vault eCOA directly compete with Suvoda's IRT/RTSM, eCOA, and eConsent offerings. Veeva is the largest publicly traded eClinical platform serving the same pharmaceutical sponsor and CRO customer base.
  • Medidata Solutions (Dassault Systèmes): Medidata's Rave RTSM, Rave EDC, and eCOA solutions directly compete with Suvoda's core IRT, EDC-adjacent, and eCOA modules. Medidata serves the same enterprise pharma sponsors and CROs at comparable scale.
  • Oracle Clinical One: Oracle's Clinical One platform combines RTSM, EDC, and clinical trial operations in a unified suite directly comparable to Suvoda's platform approach. Oracle leverages its broader enterprise software relationships to win large pharma accounts.
  • Signant Health: Signant Health provides RTSM, eCOA, and clinical supply solutions that directly overlap Suvoda's core product portfolio. The company targets the same pharmaceutical and CRO customers and competes head-to-head on mid-sized and large trials.
  • Clario: Clario offers eCOA, RTSM, cardiac safety, and imaging solutions that compete directly with Suvoda's patient-centric clinical outcome assessment and IRT offerings. Clario was formed from the merger of ERT and Bioclinica.
  • Medrio: Medrio provides EDC, eCOA, and direct data capture solutions to clinical trial sponsors and CROs. It serves a comparable mid-market segment and overlaps with Suvoda's eCOA and trial configuration capabilities.

Emerging players

  • Science 37: Science 37 pioneered decentralized clinical trial technology and competes in adjacent patient-facing and remote trial capabilities. Suvoda's unified patient app and Greenphire travel/payments overlap with Science 37's decentralized model.
  • Advarra: Advarra's Study Collaboration platform integrates with Suvoda and competing eClinical technologies, offering site-facing workflow, IRB, and technology orchestration. The integration partnership (Dec 2025) and overlap in site payments/feasibility make it a relevant adjacent peer.
  • Castor: Castor provides an eClinical platform with EDC, eCOA, and eConsent capabilities that competes in part with Suvoda's offering, particularly for smaller biotech and academic sponsors adopting cloud-based, configurable platforms.

Broad incumbents

  • IQVIA: IQVIA operates as a broad CRO and clinical technology incumbent with proprietary RTSM, EDC, and analytics offerings. Its size and CRO relationships position it as both a customer and a competitor to Suvoda in the eClinical technology market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Suvoda social profiles

Digital presence

Suvoda compliance and trust

Trust signal

Compliance3 records

Suvoda financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Suvoda leadership team

Management profile

Number of profiles

Profiles11 records

Suvoda subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Suvoda funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Suvoda M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Suvoda

What does Suvoda do?

Suvoda sells a unified, web-based clinical trial technology platform comprising eight modular products—RTSM/IRT, eCOA, eConsent, Patient Payments, Travel, Scheduling, Site Payments, and Budgeting & Benchmarking—delivered as multi-year enterprise SaaS subscriptions to pharmaceutical sponsors, CROs, and research sites. The platform is augmented by AI capabilities including the Sofia assistant and agentic RTSM, and supported by professional services for implementation, integration, and ongoing customer success.

Is Suvoda a public or private company?

Suvoda is a private company. It is classified as private equity controlled and is currently operating.

When was Suvoda founded?

Suvoda was founded in 2013. It employs 1,001 to 5,000 people.

Where is Suvoda based?

Suvoda is headquartered in Conshohocken, United States, in the North America region.

How does Suvoda make money?

One revenue line is on record: clinical Trial Software Platform.

Who are Suvoda's main competitors?

Direct peers on record are Veeva Systems, Medidata Solutions (Dassault Systèmes), Oracle Clinical One, Signant Health, Clario and Medrio. Emerging players are Science 37, Advarra and Castor. IQVIA is listed as a broad incumbent.

Does Suvoda have an API?

No public API is recorded for Suvoda.

What industry is Suvoda in?

Suvoda's product category is Clinical Trial Technology / eClinical Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LelezardSuvoda aide les patients à poursuivre leurs essais cliniques en leur offrant plus de choix et de contrôle sur leurs déplacements grâce à l'extension du programme Greenphire TravelSuvoda announced new features for its Greenphire Travel platform, extending carpooling access via Lyft, Uber Health, and Bolt to clinical trial participants. The update also offers two travel support models, including a concierge option in over 40 countries, to help sites and sponsors manage travel logistics.PR Newswire APACSuvoda helps patients stay in trials with more travel choice and control through expanded Greenphire TravelSuvoda announced new Greenphire Travel capabilities, adding global rideshare access via Lyft, Uber Health, and Bolt, and offering two service models: site-led and 24/7 concierge. The platform provides real-time trip status, consolidated reporting, and $0 out-of-pocket costs for covered travel. It aims to reduce travel barriers for clinical trial participants.AktienSuvoda helps patients stay in trials with more travel choice and control through expanded Greenphire TravelSuvoda announced expanded Greenphire Travel capabilities, adding Lyft, Uber Health, and Bolt rideshare access for clinical trial participants. The update lets participants book rides and view itineraries through the Suvoda App, while sites can choose between routine travel requests or a fully managed Concierge model across 40+ countries.AktienSuvoda hilft Patienten, durch mehr Auswahl und Kontrolle bei Reisen mit dem erweiterten Greenphire Travel in Studien zu bleibenSuvoda announced new features in Greenphire Travel to reduce travel barriers for clinical trial participants. The update adds Lyft, Uber Health, and Bolt access, and a single app for booking and managing study-related travel. A survey cited 49% of participants naming travel as a barrier.PR NewswireSuvoda hilft Patienten, durch mehr Auswahl und Kontrolle bei Reisen mit dem erweiterten Greenphire Travel in Studien zu bleibenSuvoda announced new Greenphire Travel features giving clinical trial participants access to Lyft, Uber Health, and Bolt, plus a concierge model in over 40 countries. The update aims to reduce travel coordination burdens and improve transparency, with costs covered by sponsors.PR NewswireSuvoda helps patients stay in trials with more travel choice and control through expanded Greenphire TravelSuvoda announced expanded Greenphire Travel capabilities, adding Lyft, Uber Health, and Bolt rideshare access for clinical trial participants. The platform offers two support models—site-led and 24/7 Concierge across 40+ countries—and aims to reduce travel-related barriers, which 49% of participants cited as disruptive.PR NewswireSuvoda ayuda a los pacientes a permanecer en ensayos clínicos con más opciones y controlSuvoda expanded its Greenphire Travel service to offer shared-ride options via Lyft, Uber Health, and Bolt, plus a concierge model in over 40 countries. The platform lets patients book eligible trips and view study itineraries, while sponsors fund travel costs. The update aims to reduce travel-related barriers in clinical trials.PR NewswireSuvoda helps patients stay in trials with more travel choice and control through expanded Greenphire TravelSuvoda announced expanded Greenphire Travel capabilities, adding Lyft, Uber Health, and Bolt rideshare access for clinical trial participants. The platform offers two support models—site-led and 24/7 Concierge across 40+ countries—and aims to reduce travel-related barriers, which 49% of participants cited as disruptive in a recent study.PR NewswireSuvoda aide les patients à poursuivre leurs essais cliniques en leur offrant plus de choix et de contrôle sur leurs déplacements grâce à l'extension du programme Greenphire TravelSuvoda updated Greenphire Travel to give clinical trial participants direct access to Lyft, Uber Health, and Bolt, reducing coordination work for sites. The update also adds concierge models in over 40 countries and lets sponsors choose between site-managed and fully managed travel support.PR Newswire APACSuvoda makes Sofia AI assistant available for clinical trials to drive faster answers and actionSuvoda announced that its Sofia AI assistant is now available for all new clinical trials using Suvoda RTSM/IRT or eCOA. The assistant handles routine operational work and can execute system actions after user confirmation, with a zero-data retention policy. It recently received the PM360 Innovation Award in the AI category.